Skip to content
Company Analysis

PAVmed Inc. - Series Z PAVMZ

A comprehensive view of key metrics, scores, and financial health for PAVmed Inc. - Series Z

Overview of PAVmed Inc.

PAVMZ NCM
Healthcare Medical Devices
PAVmed Inc. (PAVMZ), in the Medical Devices industry.
-
-
Previous close
Enterprise Value
-
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Weak
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Weak
Completeness: 56%
Confidence: 38%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://www.pavmed.com
HQ New York, NY
Employees 39
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Shares outstanding missing or non-positive

Engine Room Money Flow™

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$3.0M
22.1%%
Gross Profit
$-1.8M
53.5%%
Operating Income
$-44.4M
35.5%%
Net Income
$39.8M
162%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio
-84.5%
Poor

FCF / Net Income - measures how well earnings convert to cash

Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
0/3
Improving
0
High Impact
1
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating PAVmed Inc. - Series Z's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
23
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
9
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 85% Coverage
Trade-Off Triangle Visualization A ternary plot showing PAVMZ's balance between Growth (52.6%), Profitability (25.8%), and Safety (21.6%). Growth 53% Safety 22% Profitability 26%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

82th percentile vs peers
82
Key Signals
Revenue CAGR 3Y 81.6% 90p Rev Growth YoY 22.1% 75p
Strengths
  • Growth performance in top 20% of peers (percentile: 82)
  • Revenue CAGR 3Y in top 20% of peers (81.6%, 90th percentile)
  • Interest Coverage Ratio in top 20% of peers (632.71, 98th percentile)
  • Net Profit Margin in top 20% of peers (13.29, 98th percentile)
  • EBIT Margin in top 20% of peers (9.51, 98th percentile)
Risks

No significant risks identified for this axis.

Profitability

40th percentile vs peers
40
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

33th percentile vs peers
34
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for PAVmed Inc. - Series Z.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info